Clinical trial
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 is registered in ClinicalTrials.gov with Lund University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
- Lead sponsor
- Lund University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 2, 2021
- Completion date
- April 30, 2027
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.